We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+17.99%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
–
AUM
$708M
AUM Growth
+$3.54M
Cap. Flow
-$100M
Cap. Flow %
-14.16%
Top 10 Hldgs %
93.78%
Holding
22
New
2
Increased
5
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$44M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$23.5M
3
VSTS icon
Vestis
VSTS
+$21.2M
4
IART icon
Integra LifeSciences
IART
+$3.05M
5
TSVT
2seventy bio
TSVT
+$801K

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$111M
2
GIII icon
G-III Apparel Group
GIII
+$52.5M
3
PFSW
PFSweb, Inc.
PFSW
+$19.6M
4
RNAC icon
Cartesian Therapeutics
RNAC
+$3.41M
5
MBI icon
MBIA
MBI
+$3.03M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.95%
2 Healthcare 25.63%
3 Industrials 24.61%
4 Communication Services 6.69%
5 Energy 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SN icon
1
SharkNinja
SN
$21B
$188M 26.6%
3,681,914
-2,430,277
-40% -$111M
GHC icon
2
Graham Holdings Company
GHC
$4.97B
$146M 20.59%
209,401
– –
TBPH icon
3
Theravance Biopharma
TBPH
$874M
$78.8M 11.13%
7,012,226
– –
STGW icon
4
Stagwell
STGW
$1.84B
$47.4M 6.69%
7,147,662
– –
IART icon
5
Integra LifeSciences
IART
$1.54B
$45.4M 6.41%
1,042,156
+77,489
+8% +$3.05M
GIII icon
6
G-III Apparel Group
GIII
$1.47B
$45M 6.35%
1,323,110
-1,865,887
-59% -$52.5M
HES
7
DELISTED
Hess
HES
$43.3M 6.11%
+300,270
New +$44M
VSTS icon
8
Vestis
VSTS
$2.06B
$28.5M 4.02%
1,346,980
+1,236,980
+1,125% +$21.2M
MRTX
9
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$24.5M 3.46%
+417,427
New +$23.5M
ONL
10
Orion Office REIT
ONL
$148M
$17.1M 2.41%
2,989,565
-511,716
-15% -$2.67M
OVID icon
11
Ovid Therapeutics
OVID
$435M
$11.7M 1.66%
3,648,509
– –
FSP
12
Franklin Street Properties
FSP
$44.8M
$8.43M 1.19%
3,291,443
– –
TSVT
13
DELISTED
2seventy bio
TSVT
$7.49M 1.06%
1,754,788
+260,663
+17% +$801K
MACK
14
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$7.42M 1.05%
553,085
– –
GOSS icon
15
Gossamer Bio
GOSS
$66.5M
$4.61M 0.65%
5,054,472
-1,075,796
-18% -$795K
CEE
16
Central and Eastern Europe Fund
CEE
$135M
$2.67M 0.38%
273,957
+62,927
+30% +$553K
INDV icon
17
Indivior Pharmaceuticals
INDV
$4.79B
$1.1M 0.16%
72,255
+33,168
+85% +$589K
RNAC icon
18
Cartesian Therapeutics
RNAC
$232M
$402K 0.06%
19,420
-114,181
-85% -$3.41M
SFE
19
DELISTED
Safeguard Scientifics, Inc.
SFE
$207K 0.03%
264,049
-95,036
-26% -$95.8K
LNSR icon
20
LENSAR
LNSR
$68.8M
– –
-240,341
Closed -$743K
MBI icon
21
MBIA
MBI
$288M
– –
-420,826
Closed -$3.03M
PFSW
22
DELISTED
PFSweb, Inc.
PFSW
– –
-2,633,189
Closed -$19.6M

Similar funds

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
EPM
Elm Partners Management Philadelphia, Pennsylvania $2.31B AUM 16.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Madison Avenue Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Madison Avenue Partners held 22 positions worth $708M, up 0.5% from $705M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Madison Avenue Partners withdrew a net $100M in Q4 2023, closing 3 positions and reducing 6 holdings. Its most notable exit was PFSweb, Inc., an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 51% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Madison Avenue Partners opened a new position in Hess worth $43.3M.

  • Madison Avenue Partners's largest Q4 2023 buy was Hess: 300,270 shares worth $43.3M.
  • Madison Avenue Partners added most to Vestis in Q4 2023, an estimated $21.2M increase.
  • Madison Avenue Partners's biggest Q4 2023 reduction was SharkNinja, cutting an estimated $111M.
  • Madison Avenue Partners fully exited PFSweb, Inc. in Q4 2023, selling an estimated $19.6M.
  • Madison Avenue Partners's ten largest holdings make up 94% of its $708M portfolio in Q4 2023.
  • Madison Avenue Partners opened 2 new positions and closed 3 in Q4 2023.
  • Madison Avenue Partners's portfolio value rose 0.5% quarter-over-quarter to $708M.

Based on Madison Avenue Partners's 13F filing for Q4 2023, filed 16 Feb 2024.